| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | arachidonate 12(S)-lipoxygenase activity | 2.97e-05 | 4 | 45 | 2 | GO:0004052 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.61e-04 | 17 | 45 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.61e-04 | 17 | 45 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | JUN kinase binding | 6.61e-04 | 17 | 45 | 2 | GO:0008432 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.44e-03 | 25 | 45 | 2 | GO:0016702 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.56e-03 | 26 | 45 | 2 | GO:0016701 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.62e-03 | 103 | 45 | 3 | GO:0004725 | |
| Domain | SLED | 5.65e-05 | 5 | 45 | 2 | IPR021987 | |
| Domain | SLED | 5.65e-05 | 5 | 45 | 2 | PF12140 | |
| Domain | LIPOXYGENASE_2 | 8.46e-05 | 6 | 45 | 2 | PS00081 | |
| Domain | LipOase | 8.46e-05 | 6 | 45 | 2 | IPR000907 | |
| Domain | LipOase_Fe_BS | 8.46e-05 | 6 | 45 | 2 | IPR020833 | |
| Domain | LipOase_CS | 8.46e-05 | 6 | 45 | 2 | IPR020834 | |
| Domain | LipOase_mml | 8.46e-05 | 6 | 45 | 2 | IPR001885 | |
| Domain | LIPOXYGENASE_1 | 8.46e-05 | 6 | 45 | 2 | PS00711 | |
| Domain | LipOase_C | 8.46e-05 | 6 | 45 | 2 | IPR013819 | |
| Domain | Lipoxygenase | 8.46e-05 | 6 | 45 | 2 | PF00305 | |
| Domain | LIPOXYGENASE_3 | 8.46e-05 | 6 | 45 | 2 | PS51393 | |
| Domain | PTPc | 8.83e-05 | 36 | 45 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.12e-04 | 39 | 45 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.31e-04 | 41 | 45 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.31e-04 | 41 | 45 | 3 | PF00102 | |
| Domain | Sel1 | 1.57e-04 | 8 | 45 | 2 | PF08238 | |
| Domain | SEL1 | 1.57e-04 | 8 | 45 | 2 | SM00671 | |
| Domain | Sel1-like | 2.02e-04 | 9 | 45 | 2 | IPR006597 | |
| Domain | MBT | 2.02e-04 | 9 | 45 | 2 | SM00561 | |
| Domain | MBT | 2.02e-04 | 9 | 45 | 2 | PS51079 | |
| Domain | MBT | 2.52e-04 | 10 | 45 | 2 | PF02820 | |
| Domain | Mbt | 2.52e-04 | 10 | 45 | 2 | IPR004092 | |
| Domain | PTPc_motif | 3.87e-04 | 59 | 45 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.87e-04 | 59 | 45 | 3 | IPR003595 | |
| Domain | Tyr_Pase_AS | 7.23e-04 | 73 | 45 | 3 | IPR016130 | |
| Domain | LH2 | 8.47e-04 | 18 | 45 | 2 | SM00308 | |
| Domain | PLAT | 1.16e-03 | 21 | 45 | 2 | PF01477 | |
| Domain | PLAT | 1.16e-03 | 21 | 45 | 2 | PS50095 | |
| Domain | PLAT/LH2_dom | 1.16e-03 | 21 | 45 | 2 | IPR001024 | |
| Domain | - | 1.16e-03 | 21 | 45 | 2 | 2.60.60.20 | |
| Domain | TYR_PHOSPHATASE_1 | 1.16e-03 | 86 | 45 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.20e-03 | 87 | 45 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.20e-03 | 87 | 45 | 3 | IPR000387 | |
| Domain | - | 1.41e-03 | 92 | 45 | 3 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.74e-03 | 99 | 45 | 3 | IPR029021 | |
| Domain | SAM_2 | 4.81e-03 | 43 | 45 | 2 | PF07647 | |
| Domain | C-type_lectin_CS | 4.81e-03 | 43 | 45 | 2 | IPR018378 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 7832766 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7665159 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 5.36e-06 | 3 | 47 | 2 | 31985401 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20139422 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 25703008 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 5.36e-06 | 3 | 47 | 2 | 33656439 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 8524829 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 24005813 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 22357843 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 10777529 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 19273906 | ||
| Pubmed | Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles. | 2.67e-05 | 6 | 47 | 2 | 21577013 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | B3GALNT1 PLA2R1 EXT2 SELENOI POGLUT2 PTPRF MANEAL SYMPK SEL1L3 | 2.83e-05 | 1201 | 47 | 9 | 35696571 |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 29073098 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 12376545 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 28637841 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 37591863 | ||
| Pubmed | 6.40e-05 | 9 | 47 | 2 | 12436047 | ||
| Pubmed | GC-B Deficient Mice With Axon Bifurcation Loss Exhibit Compromised Auditory Processing. | 9.75e-05 | 11 | 47 | 2 | 30275816 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 25624497 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | 1.02e-04 | 345 | 47 | 5 | 15164054 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 1.17e-04 | 12 | 47 | 2 | 9624153 | |
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 2.40e-04 | 17 | 47 | 2 | 19727691 | |
| Pubmed | 5.69e-04 | 26 | 47 | 2 | 36178190 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 6.65e-04 | 1105 | 47 | 7 | 35748872 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 2.37e-04 | 294 | 47 | 4 | chr1p34 | |
| Cytoband | 1p34 | 4.99e-04 | 32 | 47 | 2 | 1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 9.75e-04 | 189 | 47 | 3 | chr10q24 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.90e-06 | 21 | 34 | 3 | 813 | |
| GeneFamily | Arachidonate lipoxygenases | 5.12e-05 | 6 | 34 | 2 | 407 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.23e-04 | 9 | 34 | 2 | 1263 | |
| GeneFamily | Sterile alpha motif domain containing | 1.19e-02 | 88 | 34 | 2 | 760 | |
| GeneFamily | Actins|Deafness associated genes | 1.91e-02 | 113 | 34 | 2 | 1152 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-05 | 157 | 47 | 4 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 160 | 47 | 4 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 175 | 47 | 4 | 21bc0e59a9509d38751ce6aad2325f341bc70eff | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.54e-05 | 176 | 47 | 4 | 67d6dc38708692f8c58cea5ed896f10718e9ffa6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.54e-05 | 176 | 47 | 4 | 125be81311f87563ca321472fcce6e0e0ae24c16 | |
| ToppCell | wk_15-18-Epithelial-PNS-Schwann_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 177 | 47 | 4 | 5357359e6c2161a37f39a6b3b78449f5cbc327d1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 177 | 47 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 177 | 47 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 179 | 47 | 4 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | 4.03e-05 | 182 | 47 | 4 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.12e-05 | 183 | 47 | 4 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 188 | 47 | 4 | 6b0e0192519ea3ca49fb21de3da9a0a108fcb64d | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.58e-05 | 188 | 47 | 4 | 0b19c35fdc2b9e064e8f03ef69ae08644794ec24 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-05 | 191 | 47 | 4 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | 4187f31ec399b4c7c3608e94e3c32b7a54b1c3d4 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | 8e8bc200524a44ebe132f823ab7c15dac65d4952 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-05 | 192 | 47 | 4 | 3dddfc93c3c954c4416c7c1f1f161e4d1dcc1233 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 193 | 47 | 4 | 89831e1007944e47719e58f23bfef5f1944cae23 | |
| ToppCell | B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.17e-05 | 194 | 47 | 4 | 22b87fe2bb84632ddcef8f1d7742021728e2246d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-05 | 194 | 47 | 4 | 1b9ec27cdd52a54b55e4ad89162e8a170d57c017 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.27e-05 | 195 | 47 | 4 | d11d559a3afcb8ae845edea14d4cfeb41d82e165 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.27e-05 | 195 | 47 | 4 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 196 | 47 | 4 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 119 | 47 | 3 | aa3860c8d25c85baa79a0b6637bce2e269adfcc2 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.40e-04 | 129 | 47 | 3 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_Naive|URO / Disease, Lineage and Cell Type | 3.81e-04 | 134 | 47 | 3 | 142b7db0c2b686c8f2704ff7bcd9b44dfcb07403 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.15e-04 | 138 | 47 | 3 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 4.15e-04 | 138 | 47 | 3 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-04 | 141 | 47 | 3 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-04 | 141 | 47 | 3 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.51e-04 | 142 | 47 | 3 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.79e-04 | 145 | 47 | 3 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.09e-04 | 148 | 47 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.09e-04 | 148 | 47 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-04 | 150 | 47 | 3 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-04 | 150 | 47 | 3 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-04 | 150 | 47 | 3 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 5.50e-04 | 152 | 47 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.71e-04 | 154 | 47 | 3 | 0627161adaac5ee1f4aff05872b41473e6ae6eaf | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.82e-04 | 155 | 47 | 3 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.82e-04 | 155 | 47 | 3 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.93e-04 | 156 | 47 | 3 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 5.93e-04 | 156 | 47 | 3 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.04e-04 | 157 | 47 | 3 | 62f029831c420d3e9580822177545eb7fdf4d0a3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.04e-04 | 157 | 47 | 3 | 63502d0fd5972d71cdbe13bde167592c70acec32 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-04 | 157 | 47 | 3 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 158 | 47 | 3 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | CD8+_Memory_T_cell-RSV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.15e-04 | 158 | 47 | 3 | 5ae737757a49fc96bde1e57e02066f9f65654ea1 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.15e-04 | 158 | 47 | 3 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-04 | 158 | 47 | 3 | 5d8a345df1d3001f34740b9f2f5f92f5428bbee6 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.27e-04 | 159 | 47 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | 6.27e-04 | 159 | 47 | 3 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.27e-04 | 159 | 47 | 3 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | LAM-Lymphoid-B-cell-2|LAM / Condition, Lineage and Cell class | 6.38e-04 | 160 | 47 | 3 | 0060c2b3304f411c682aa2ba20bcf80f346d2403 | |
| ToppCell | severe_influenza-cDC|World / disease group, cell group and cell class (v2) | 6.50e-04 | 161 | 47 | 3 | 802f8cafb5f499e3b2ec0193d6eb1ac9320b9287 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-04 | 161 | 47 | 3 | b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c | |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-04 | 162 | 47 | 3 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 | |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-04 | 162 | 47 | 3 | f945688815229c8386cbcbf46deee7df316fa8d3 | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 6.85e-04 | 164 | 47 | 3 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 6.85e-04 | 164 | 47 | 3 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 6.85e-04 | 164 | 47 | 3 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.85e-04 | 164 | 47 | 3 | 74a35ba77e93d864161beb6b133d654473981bb7 | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.98e-04 | 165 | 47 | 3 | d8b0a9b6f704b98e8f0412c11739879a26c036e2 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 6e6075d0c913e2516083f6dcab21d5878bcef7a4 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.10e-04 | 166 | 47 | 3 | 1ca888ae8168707493f19ee52a89d7c70e6cb51d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 4fbe44e0aea197893614cd55f83119aa0f73ee53 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.10e-04 | 166 | 47 | 3 | 4cba4ca1aa2321b9ef7cd230932b890d2434a252 | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-04 | 167 | 47 | 3 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-04 | 167 | 47 | 3 | f2185eb72f0137136f6d71af2a70168fded6c940 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.22e-04 | 167 | 47 | 3 | 5e768cf24699893e05d1bcb1c92dba2336943a64 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-04 | 168 | 47 | 3 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Tuft-tuft-1|World / Class top | 7.35e-04 | 168 | 47 | 3 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.35e-04 | 168 | 47 | 3 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 7.35e-04 | 168 | 47 | 3 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 169 | 47 | 3 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 170 | 47 | 3 | c638dfde9ce30190abbe0caea1c3eb874af09857 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-04 | 171 | 47 | 3 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-04 | 172 | 47 | 3 | d40a8bd61114b49a5837c836136a13c37c8f7de0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-04 | 172 | 47 | 3 | 3aed10e6db48254f4cae12fbe52d1a1fc6cf2dce | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-04 | 172 | 47 | 3 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | ca3d2a9562734f76127e3e7d54c10b63e95141bb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | b413a8554868e3c09275948b6605f7dc7f7277fd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.00e-04 | 173 | 47 | 3 | 0ca2169a275404118038c0489a48062879488765 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.00e-04 | 173 | 47 | 3 | 68bcc0eee15df9cf3516c641709154301bd7b38f | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 19a9e10885173d7712996be8660a3a5a7a9aa39f | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.00e-04 | 173 | 47 | 3 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 174 | 47 | 3 | 009e88a6c79689a5d88b0af50aa89aa03b33f800 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 174 | 47 | 3 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 8.13e-04 | 174 | 47 | 3 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 8.27e-04 | 175 | 47 | 3 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.27e-04 | 175 | 47 | 3 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-04 | 175 | 47 | 3 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-04 | 175 | 47 | 3 | c3d3f11602379aaba65842a98835299e54fccd84 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 8.27e-04 | 175 | 47 | 3 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| Drug | AC1NR1PE | 2.39e-05 | 4 | 46 | 2 | CID005283182 | |
| Drug | R 68 151 | 2.39e-05 | 4 | 46 | 2 | CID000132150 | |
| Drug | AC1L4ENC | 2.39e-05 | 4 | 46 | 2 | CID000155619 | |
| Drug | C02639 | 2.39e-05 | 4 | 46 | 2 | CID000439776 | |
| Drug | 19-hydroxy-PGB2 | 3.98e-05 | 5 | 46 | 2 | CID005283111 | |
| Drug | artonin E | 3.98e-05 | 5 | 46 | 2 | CID005481962 | |
| Drug | 6,7,4'-trihydroxyisoflavan | 3.98e-05 | 5 | 46 | 2 | CID000125101 | |
| Drug | tixocortolum | 5.96e-05 | 6 | 46 | 2 | CID000162955 | |
| Drug | isamoxole | 5.96e-05 | 6 | 46 | 2 | CID000042118 | |
| Drug | 1-oleoyl-2-DHA-PC | 5.96e-05 | 6 | 46 | 2 | CID006438829 | |
| Drug | CPHU | 5.96e-05 | 6 | 46 | 2 | CID000124471 | |
| Drug | BW A797C | 5.96e-05 | 6 | 46 | 2 | CID006439067 | |
| Drug | tricarbon | 6.70e-05 | 39 | 46 | 3 | CID006432003 | |
| Drug | benoxaprofen | 7.80e-05 | 41 | 46 | 3 | CID000039941 | |
| Drug | AHR-5333 | 8.33e-05 | 7 | 46 | 2 | CID000173727 | |
| Drug | AC1L1G9H | 8.33e-05 | 7 | 46 | 2 | CID000003587 | |
| Drug | knipholone | 8.33e-05 | 7 | 46 | 2 | CID000442753 | |
| Drug | 12-IODE | 8.33e-05 | 7 | 46 | 2 | CID006450050 | |
| Drug | 10,11-dihydro-LTB4 | 8.33e-05 | 7 | 46 | 2 | CID006439070 | |
| Drug | 12-HPETE | 9.00e-05 | 43 | 46 | 3 | CID000001415 | |
| Drug | SRI 63-675 | 1.11e-04 | 8 | 46 | 2 | CID000122013 | |
| Drug | colneleic acid | 1.11e-04 | 8 | 46 | 2 | CID006441681 | |
| Drug | Cgs 22745 | 1.11e-04 | 8 | 46 | 2 | CID006439321 | |
| Drug | AC1NUP73 | 1.11e-04 | 8 | 46 | 2 | CID005487167 | |
| Drug | htyA | 1.11e-04 | 8 | 46 | 2 | CID000152267 | |
| Drug | CDNQ | 1.11e-04 | 8 | 46 | 2 | CID000126468 | |
| Drug | 15-HPEPE | 1.11e-04 | 8 | 46 | 2 | CID006438853 | |
| Drug | neobaicalein | 1.11e-04 | 8 | 46 | 2 | CID000124211 | |
| Drug | 14,15-leukotriene A4 | 1.42e-04 | 9 | 46 | 2 | CID006439604 | |
| Drug | octadeca-9,12-dien-1-ol | 1.42e-04 | 9 | 46 | 2 | CID000068168 | |
| Drug | U-56467 | 1.42e-04 | 9 | 46 | 2 | CID006439532 | |
| Drug | 8,15-diHPETE | 1.42e-04 | 9 | 46 | 2 | CID005283181 | |
| Drug | 13-hydroxylinoleic acid | 1.42e-04 | 9 | 46 | 2 | CID006438633 | |
| Drug | AC1NSXHC | 1.42e-04 | 9 | 46 | 2 | CID005371969 | |
| Drug | U-66,855 | 1.42e-04 | 9 | 46 | 2 | CID000127235 | |
| Drug | 5,6-methanoleukotriene A4 | 1.42e-04 | 9 | 46 | 2 | CID006439643 | |
| Drug | ODYA | 1.42e-04 | 9 | 46 | 2 | CID000001931 | |
| Drug | KME-4 | 1.42e-04 | 9 | 46 | 2 | CID006438990 | |
| Drug | A-78773 | 1.42e-04 | 9 | 46 | 2 | CID000071460 | |
| Drug | 9-HPODE | 1.78e-04 | 10 | 46 | 2 | CID000001928 | |
| Drug | 1,4-pentadiene | 1.78e-04 | 10 | 46 | 2 | CID000011587 | |
| Drug | esculetin | 1.98e-04 | 56 | 46 | 3 | CID005281416 | |
| Drug | Ia 5 | 2.17e-04 | 11 | 46 | 2 | CID000032247 | |
| Drug | acetone phenylhydrazone | 2.17e-04 | 11 | 46 | 2 | CID000066026 | |
| Drug | Ity A | 2.17e-04 | 11 | 46 | 2 | CID000188274 | |
| Drug | BW A137C | 2.17e-04 | 11 | 46 | 2 | CID000129265 | |
| Drug | 12-KETE | 2.60e-04 | 12 | 46 | 2 | CID005283162 | |
| Drug | nonenal | 2.60e-04 | 12 | 46 | 2 | CID003015503 | |
| Drug | IC-1 | 2.60e-04 | 12 | 46 | 2 | CID000049829 | |
| Drug | AMD3465 | 2.60e-04 | 12 | 46 | 2 | CID000483559 | |
| Drug | AC1NR1Q2 | 3.07e-04 | 13 | 46 | 2 | CID005283190 | |
| Drug | AC1L1BGZ | 3.07e-04 | 13 | 46 | 2 | CID000001435 | |
| Drug | 9-HETE | 3.07e-04 | 13 | 46 | 2 | CID000001926 | |
| Drug | hypolaetin | 3.07e-04 | 13 | 46 | 2 | CID005281648 | |
| Drug | ICI207968 | 3.07e-04 | 13 | 46 | 2 | CID000129095 | |
| Drug | AC1O4E1A | 3.07e-04 | 13 | 46 | 2 | CID006365736 | |
| Drug | gossypetin | 3.58e-04 | 14 | 46 | 2 | CID005280647 | |
| Drug | AC1NR1LB | 3.58e-04 | 14 | 46 | 2 | CID005283131 | |
| Drug | oxphaman | 3.58e-04 | 14 | 46 | 2 | CID005464022 | |
| Drug | timegadine | 3.58e-04 | 14 | 46 | 2 | CID000068902 | |
| Drug | 5-HEPE | 3.58e-04 | 14 | 46 | 2 | CID000001766 | |
| Drug | 17-HdoHE | 3.58e-04 | 14 | 46 | 2 | CID006439179 | |
| Drug | ONO-RS-082 | 3.84e-04 | 70 | 46 | 3 | CID006438389 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.92e-04 | 171 | 46 | 4 | 2723_DN | |
| Drug | 8R-HpETE | 4.12e-04 | 15 | 46 | 2 | CID005283170 | |
| Drug | Hex-3-enyl acetate | 4.12e-04 | 15 | 46 | 2 | CID000015574 | |
| Drug | 8(S),15(S)-diHETE | 4.12e-04 | 15 | 46 | 2 | CID000001897 | |
| Drug | 13-HpOTrE | 4.12e-04 | 15 | 46 | 2 | CID005282866 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.19e-04 | 174 | 46 | 4 | 6579_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.19e-04 | 174 | 46 | 4 | 5940_DN | |
| Drug | Ia 4 | 4.71e-04 | 16 | 46 | 2 | CID000032249 | |
| Drug | AC1NR1M2 | 4.71e-04 | 16 | 46 | 2 | CID005283140 | |
| Drug | 12R-HETrE | 4.71e-04 | 16 | 46 | 2 | CID005283149 | |
| Drug | peroxylinolenic acid | 4.71e-04 | 16 | 46 | 2 | CID006439905 | |
| Drug | hex-3-enal | 4.71e-04 | 16 | 46 | 2 | CID000023234 | |
| Drug | sinensetin | 4.71e-04 | 16 | 46 | 2 | CID000145659 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.86e-04 | 181 | 46 | 4 | 7005_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 5.17e-04 | 184 | 46 | 4 | 6939_DN | |
| Drug | 5,15-diHETE | 5.33e-04 | 17 | 46 | 2 | CID005283158 | |
| Drug | cirsiliol | 5.33e-04 | 17 | 46 | 2 | CID000160237 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.38e-04 | 186 | 46 | 4 | 6874_DN | |
| Drug | FPL 57231 | 5.99e-04 | 18 | 46 | 2 | CID000122212 | |
| Drug | 3-nonenal | 5.99e-04 | 18 | 46 | 2 | CID005283336 | |
| Drug | BW540C | 5.99e-04 | 18 | 46 | 2 | CID000134372 | |
| Drug | AC1O5PL5 | 5.99e-04 | 18 | 46 | 2 | CID006438380 | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 6946_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HG-U133A | 6.30e-04 | 194 | 46 | 4 | 409_UP | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; PC3; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 4260_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; PC3; HT_HG-U133A | 6.43e-04 | 195 | 46 | 4 | 3804_UP | |
| Drug | trichostatin A; Up 200; 0.1uM; HL60; HG-U133A | 6.43e-04 | 195 | 46 | 4 | 364_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 6.55e-04 | 196 | 46 | 4 | 1344_UP | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HT_HG-U133A | 6.55e-04 | 196 | 46 | 4 | 4257_UP | |
| Drug | troglitazone; Up 200; 10uM; SKMEL5; HG-U133A | 6.68e-04 | 197 | 46 | 4 | 504_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; HL60; HT_HG-U133A | 6.68e-04 | 197 | 46 | 4 | 2902_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A | 6.80e-04 | 198 | 46 | 4 | 2989_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 6.80e-04 | 198 | 46 | 4 | 3707_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; HL60; HT_HG-U133A | 6.93e-04 | 199 | 46 | 4 | 3089_UP | |
| Drug | Phencyclidine | 7.02e-04 | 86 | 46 | 3 | ctd:D010622 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.65e-04 | 71 | 44 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | Testicular Germ Cell Tumor | 1.96e-04 | 14 | 44 | 2 | C1336708 | |
| Disease | Pancreatic carcinoma | 3.66e-04 | 19 | 44 | 2 | C0235974 | |
| Disease | gestational age, birth measurement | 4.48e-04 | 21 | 44 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | Attention deficit hyperactivity disorder | 5.87e-04 | 24 | 44 | 2 | C1263846 | |
| Disease | azoospermia (implicated_via_orthology) | 7.45e-04 | 27 | 44 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | blood viscosity | 9.83e-04 | 31 | 44 | 2 | EFO_0004301 | |
| Disease | Hereditary hearing loss and deafness | 1.35e-03 | 146 | 44 | 3 | cv:C0236038 | |
| Disease | Mood Disorders | 2.02e-03 | 168 | 44 | 3 | C0525045 | |
| Disease | monoclonal gammopathy | 2.85e-03 | 53 | 44 | 2 | EFO_0000203 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APYWILATDYENYAL | 116 | P05090 | |
| ARLYYFWDPDYQEAL | 121 | Q9HC16 | |
| WTKYEEENFYLEPYL | 81 | P14927 | |
| AVIGLPYYLFVWEDY | 226 | Q9NW15 | |
| PYYLFVWEDYDKYVI | 231 | Q9NW15 | |
| DRYWPDEGASLYHVY | 821 | Q16849 | |
| PPEYEFFWGLRSYYE | 436 | Q9UNF1 | |
| ADRDQATYYRFWYPK | 226 | Q4G1C9 | |
| DEQWTPFLYDFYHYF | 331 | P30989 | |
| LVELQAEDYWYEAYN | 516 | Q9UQF2 | |
| WYYYDSILPSFRELA | 366 | P56696 | |
| IPNWLYLAAYFIAYF | 271 | Q13585 | |
| RVNWMYFYEYEPIYR | 46 | O75752 | |
| PLSYRQEAYWAQYRA | 211 | Q9HA72 | |
| YDHWADRFEDLPLYF | 471 | Q96RR1 | |
| AAYYYQRQDVEADPW | 126 | Q9Y4U1 | |
| YFWELFGIRPDDYLY | 96 | A2A3N6 | |
| DYEDEFLRYLWRDYL | 26 | O43613 | |
| YVDFREYEYDLKWEF | 591 | P36888 | |
| WHQVEYYRYIRFFPD | 291 | Q9UK97 | |
| YYYRDDSLAVWNALE | 496 | O75342 | |
| LFYIYDSYLTSPEAW | 266 | Q5VSG8 | |
| EAWYEPFLFNFLYRD | 206 | Q9C0D9 | |
| REDFYYSEFYPWSPD | 711 | Q9NRM1 | |
| EGNFNWRYLFPFDYL | 1786 | Q9HC10 | |
| QYWPAERSARYQYFV | 1751 | P10586 | |
| QYWPAERSARYQYFV | 1756 | P23468 | |
| YCYYFNEDPETWVDA | 46 | P48304 | |
| DNYPLDWELSYAYYS | 621 | Q68CR1 | |
| ALHWAPARCEEYDYY | 21 | Q5T4F7 | |
| ANRESLYDFWEYYLP | 181 | Q6UX01 | |
| IPYYFYRDDGLLVWE | 466 | P09917 | |
| DRTYFFKDQLYWRYD | 441 | Q9ULZ9 | |
| DWDIYQYYKFLAERG | 281 | Q5TEA6 | |
| DYDYLVLSPFALPYW | 1341 | Q9UHV7 | |
| QYDVPWLFYQDAEYL | 811 | Q13018 | |
| DWLYEHRYNAYPSEQ | 181 | Q15583 | |
| DWRTERLFDLYYYDG | 691 | Q4G0A6 | |
| SYVFYWRDYFEDQPL | 136 | Q9NWX6 | |
| DRIYPYAAISYEEWN | 416 | Q93063 | |
| TESYDQWLFYLDYRL | 226 | Q5VUG0 | |
| EMWLYRNPYVEAEYF | 41 | Q8NEB5 | |
| DSIYYEHFYNELQPW | 391 | Q6UW63 | |
| LDLAFAWLYQEYNAY | 616 | Q92797 | |
| IWRYEEKCYYLPFED | 71 | Q8TCE9 | |
| YSNPDLFWYRIRPDY | 46 | A0JD37 | |
| WDQLEYYFPTYENDT | 391 | Q9NRM2 | |
| SSDNYEHWLYYLDPF | 201 | Q9UHJ3 |